Rhodes Jason P

Number of records: 50
SEC FilingCompany/StockTrade DateTransactionSharesAvg. PriceTotal% HoldingsGain/Loss
18-Nov-24 5:31 PM
View: 
Dyne Therapeutics, Inc. (DYN) 14-Nov-24Private Sale 782$33.10$25,884.20(< 1%)
8.02M to 8.02M
05-Mar-24 5:08 PM
View: 
Dyne Therapeutics, Inc. (DYN) 01-Mar-24Private Sale (Planned) 46,534$30.05$1,398,350.00(< 1%)
8.05M to 8.0M
28-Feb-24 7:15 PM
View: 
Dyne Therapeutics, Inc. (DYN) 28-Feb-24Sale (Planned) 190,920$24.84$4,741,800.00(2%)
8.24M to 8.05M
28-Feb-24 7:15 PM
View: 
Dyne Therapeutics, Inc. (DYN) 27-Feb-24Sale (Planned) 368,699$24.41$8,998,430.00(4%)
8.61M to 8.24M
28-Feb-24 7:15 PM
View: 
Dyne Therapeutics, Inc. (DYN) 26-Feb-24Private Sale (Planned) 248,219$23.72$5,886,670.00(3%)
8.86M to 8.61M
23-Feb-24 6:59 PM
View: 
Dyne Therapeutics, Inc. (DYN) 23-Feb-24Sale (Planned) 196,928$22.70$4,470,270.00(2%)
9.06M to 8.86M
23-Feb-24 6:59 PM
View: 
Dyne Therapeutics, Inc. (DYN) 22-Feb-24Sale (Planned)
Duplicate
119,360$22.66$2,704,700.00(1%)
9.17M to 9.06M
23-Feb-24 6:59 PM
View: 
Dyne Therapeutics, Inc. (DYN) 21-Feb-24Private Sale (Planned)
Duplicate
184,501$22.57$4,164,820.00(2%)
9.36M to 9.17M
20-Feb-24 6:36 PM
View: 
Dyne Therapeutics, Inc. (DYN) 20-Feb-24Sale (Planned)
Duplicate
169,539$22.72$3,852,650.00(2%)
9.53M to 9.36M
20-Feb-24 6:36 PM
View: 
Dyne Therapeutics, Inc. (DYN) 16-Feb-24Sale (Planned)
Duplicate
162,707$23.14$3,765,040.00(2%)
9.69M to 9.53M
20-Feb-24 6:36 PM
View: 
Dyne Therapeutics, Inc. (DYN) 15-Feb-24Private Sale (Planned)
Duplicate
177,906$23.89$4,249,600.00(2%)
9.87M to 9.69M
14-Dec-22 4:56 PM
View: 
Dyne Therapeutics, Inc. (DYN) 12-Dec-22Market Purchase
Duplicate
934,581$10.70$10,000,000.0010%
8.93M to 9.87M
1%
29-Sep-21 7:16 PM
View: 
Generation Bio Co. (GBIO) 29-Sep-21Market Sale (Planned) 16,586$24.59$407,850.00(< 1%)
8.3M to 8.28M
(2%)
29-Sep-21 7:16 PM
View: 
Generation Bio Co. (GBIO) 28-Sep-21Market Sale (Planned) 13,113$25.24$330,972.00(< 1%)
8.31M to 8.3M
< 1%
29-Sep-21 7:16 PM
View: 
Generation Bio Co. (GBIO) 27-Sep-21Market Sale (Planned) 51,389$25.70$1,320,700.00(< 1%)
8.36M to 8.31M
3%
24-Sep-21 10:00 PM
View: 
Generation Bio Co. (GBIO) 24-Sep-21Market Sale (Planned) 28,916$25.84$747,161.00(< 1%)
8.39M to 8.36M
2%
24-Sep-21 10:00 PM
View: 
Generation Bio Co. (GBIO) 23-Sep-21Market Sale (Planned) 75,465$26.13$1,972,130.00(< 1%)
8.46M to 8.39M
3%
24-Sep-21 10:00 PM
View: 
Generation Bio Co. (GBIO) 22-Sep-21Market Sale (Planned) 30,617$25.89$792,705.00(< 1%)
8.5M to 8.46M
2%
28-Jun-21 4:57 PM
View: 
Generation Bio Co. (GBIO) 24-Jun-21Market Sale (Planned) 31,008$25.85$801,618.00(< 1%)
9.41M to 9.38M
(4%)
23-Jun-21 8:27 PM
View: 
Generation Bio Co. (GBIO) 23-Jun-21Market Sale (Planned) 62,609$25.36$1,587,550.00(< 1%)
9.47M to 9.41M
(1%)
23-Jun-21 8:27 PM
View: 
Generation Bio Co. (GBIO) 22-Jun-21Market Sale (Planned) 58,577$24.95$1,461,480.00(< 1%)
9.53M to 9.47M
(3%)
23-Jun-21 8:27 PM
View: 
Generation Bio Co. (GBIO) 21-Jun-21Market Sale (Planned) 63,892$24.84$1,586,940.00(< 1%)
9.6M to 9.53M
(3%)
14-Apr-21 8:20 PM
View: 
Generation Bio Co. (GBIO) 14-Apr-21Market Sale (Planned)
Duplicate
23,413$26.61$622,995.00(< 1%)
10.5M to 10.48M
< 1%
14-Apr-21 8:20 PM
View: 
Generation Bio Co. (GBIO) 13-Apr-21Market Sale (Planned)
Duplicate
43,145$25.17$1,085,740.00(< 1%)
10.55M to 10.5M
(6%)
14-Apr-21 8:20 PM
View: 
Generation Bio Co. (GBIO) 12-Apr-21Market Sale (Planned)
Duplicate
74,124$26.15$1,938,230.00(< 1%)
10.62M to 10.55M
(2%)
09-Apr-21 8:53 PM
View: 
Generation Bio Co. (GBIO) 09-Apr-21Market Sale (Planned)
Duplicate
43,681$27.61$1,205,950.00(< 1%)
10.66M to 10.62M
1%
09-Apr-21 8:53 PM
View: 
Generation Bio Co. (GBIO) 08-Apr-21Market Sale (Planned)
Duplicate
43,550$28.50$1,241,240.00(< 1%)
10.71M to 10.66M
5%
09-Apr-21 8:53 PM
View: 
Generation Bio Co. (GBIO) 07-Apr-21Market Sale (Planned)
Duplicate
39,864$28.51$1,136,670.00(< 1%)
10.75M to 10.71M
5%
28-Jan-21 5:08 PM
View: 
Replimune Group, Inc. (REPL) 26-Jan-21Market Sale (Planned) 5,558$46.14$256,446.00(< 1%)
3.23M to 3.23M
15%
22-Dec-20 4:38 PM
View: 
Replimune Group, Inc. (REPL) 18-Dec-20Market Sale (Planned) 4,319$41.95$181,182.00(< 1%)
3.24M to 3.23M
< 1%
17-Dec-20 6:21 PM
View: 
Replimune Group, Inc. (REPL) 17-Dec-20Market Sale (Planned) 11,535$42.00$484,470.00(< 1%)
3.25M to 3.24M
< 1%
17-Dec-20 6:21 PM
View: 
Replimune Group, Inc. (REPL) 16-Dec-20Market Sale (Planned) 12,675$42.13$533,998.00(< 1%)
3.26M to 3.25M
< 1%
17-Dec-20 6:21 PM
View: 
Replimune Group, Inc. (REPL) 15-Dec-20Market Sale (Planned) 40,819$42.41$1,731,250.00(1%)
3.3M to 3.26M
1%
14-Dec-20 7:20 PM
View: 
Replimune Group, Inc. (REPL) 14-Dec-20Market Sale (Planned) 37,659$43.49$1,637,850.00(1%)
3.34M to 3.3M
4%
14-Dec-20 7:20 PM
View: 
Replimune Group, Inc. (REPL) 11-Dec-20Market Sale (Planned) 31,636$43.38$1,372,510.00(< 1%)
3.37M to 3.34M
4%
14-Dec-20 7:20 PM
View: 
Replimune Group, Inc. (REPL) 10-Dec-20Market Sale (Planned) 34,391$43.15$1,484,080.00(1%)
3.41M to 3.37M
3%
09-Dec-20 7:54 PM
View: 
Replimune Group, Inc. (REPL) 09-Dec-20Market Sale (Planned) 41,216$43.77$1,804,180.00(1%)
3.45M to 3.41M
4%
09-Dec-20 7:54 PM
View: 
Replimune Group, Inc. (REPL) 08-Dec-20Market Sale (Planned) 108,256$46.71$5,056,590.00(3%)
3.56M to 3.45M
10%
09-Dec-20 7:54 PM
View: 
Replimune Group, Inc. (REPL) 07-Dec-20Market Sale (Planned) 67,890$45.96$3,120,460.00(2%)
3.62M to 3.56M
9%
23-Sep-20 7:00 PM
View: 
Dyne Therapeutics, Inc. (DYN) 21-Sep-20Conversion
Duplicate
7,638,510----362%
2.11M to 9.75M
18-Jun-20 5:28 PM
View: 
Generation Bio Co. (GBIO) 16-Jun-20Conversion
Duplicate
10,040,000----388%
2.59M to 12.63M
20-Nov-19 5:50 PM
View: 
Replimune Group, Inc. (REPL) 18-Nov-19Market Purchase 1,100,000$13.61$14,971,000.0029%
3.83M to 4.93M
207%
26-Jul-18 5:19 PM
View: 
Replimune Group, Inc. (REPL) 24-Jul-18Conversion
Duplicate
4,453,390----100%
0 to 4.45M
24-Sep-14 6:15 PM
View: 
Epizyme, Inc. (EPZM) 22-Sep-14Option Exercise 44,000$0.51$22,440.0047%
94.0K to 138.0K
04-Sep-14 6:41 PM
View: 
Epizyme, Inc. (EPZM) 02-Sep-14Option Exercise 42,000$1.02$42,840.0051%
82.0K to 124.0K
04-Sep-14 6:41 PM
View: 
Epizyme, Inc. (EPZM) 02-Sep-14Market Option Sale (Planned) 30,000$33.47$1,004,160.00(24%)
124.0K to 94.0K
67%
05-Aug-14 6:28 PM
View: 
Epizyme, Inc. (EPZM) 04-Aug-14Option Exercise 42,000$1.16$48,720.0060%
70.0K to 112.0K
05-Aug-14 6:28 PM
View: 
Epizyme, Inc. (EPZM) 04-Aug-14Market Option Sale (Planned) 30,000$29.74$892,324.00(27%)
112.0K to 82.0K
63%
09-Jul-14 6:16 PM
View: 
Epizyme, Inc. (EPZM) 07-Jul-14Option Exercise 42,000$0.95$39,960.0072%
58.0K to 100.0K
09-Jul-14 6:16 PM
View: 
Epizyme, Inc. (EPZM) 07-Jul-14Market Option Sale (Planned) 30,000$32.74$982,161.00(30%)
100.0K to 70.0K
67%